SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge.
Queille-Roussel
C
C
Centre de Pharmacologie Clinique Appliquée à la Dermatologie, France.
Graeber
M
M
Thurston
M
M
Lachapelle
J M
JM
Decroix
J
J
de Cuyper
C
C
Ortonne
J P
JP
D000287:Administration, Topical; D000485:Allergens / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D009532:Nickel / Q000009:adverse effects*; D009824:Ointments; D010328:Patch Tests; D012867:Skin / Q000187:drug effects*; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000485:Allergens; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D009824:Ointments; C117268:pimecrolimus; D009532:Nickel; D016559:Tacrolimus